IP Verse

Systems And Methods To Detect Rare Mutations And Copy Number Variation

Patent No. EP3591073 (titled "Systems And Methods To Detect Rare Mutations And Copy Number Variation") was filed by Guardant Health on Sep 4, 2013. The application was issued on Dec 1, 2021.

Patent Summary

A method for detecting and quantifying genetic alterations in cell-free DNA from bodily fluids, comprising tagging and amplifying the DNA, sequencing the tagged DNA, and analyzing the sequence data to identify rare mutations and copy number variations. The method enables the detection of genetic aberrations associated with disease, including cancer, through the analysis of cell-free DNA in bodily fluids.

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBSep 1, 2022GRUNECKER PATENT
MARGARET DIXONSep 1, 2022MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3591073

GUARDANT HEALTH
Application Number
EP19192885A
Filing Date
Sep 4, 2013
Status
Granted And Under Opposition
Oct 29, 2021
Publication Date
Dec 1, 2021
External Links
Slate, EP3591073B1, Google Patents